Skip to content
Search

Latest Stories

Invatech Health sells its care homes electronic medication administration system to PCS

Health technology pioneer Invatech Health has sold its care homes electronic medication administration record (eMAR) system Atlas to care home management specialists Person Centred Software (PCS).

Following the transition of Atlas to new ownership, Bristol-based Invatech Health will concentrate solely on further growth of Titan, its cutting-edge software for pharmacy management.


Invatech Health CEO Tariq Muhammad, a pharmacist who started working on care homes back in 2002, first conceived the concept of electronic medicines system for care homes in 2006.

Muhammad said he was proud to see his purpose-driven business given an opportunity for further progress. “It’s a bit like being at a child’s graduation,” he said, after the completion of the acquisition which marked the end of a 20 year journey for him with Atlas.

“I set up Atlas to tackle a dire need in the care homes sector for a system which could prevent incorrect dosing, mismanagement of prescriptions and administration errors of important medication.

“For me Atlas has always been about the end user – care homes and their residents. It’s taken a long time to perfect it and, as with any business, there have been bumps along the way.

"Now I’ve taken Atlas as far as I can, so I’m delighted to see it under new ownership, with a company whose values I share and who can allow it to reach greater heights as part of a new ecosystem.

“It’s a clean acquisition, with a complete continuation in staffing and functionality, so it couldn’t have happened any better for all involved.

“My management team and I will oversee the transition over coming months to ensure Atlas is properly bedded in. We can then focus all our efforts into the exciting development of Titan – a similarly cutting-edge product and the equivalent in the rapidly-growing pharmacy sector.

“The potential for Titan is massive. So while I’ve seen one brainchild flying the nest today, there’s another one growing rapidly which needs our full attention.”

PCS, which is based in Guildford in Surrey, confirmed that as part of the acquisition it would retain Atlas’s full team of 15 staff, all of whom work remotely.

Atlas is currently deployed in 700 care homes across the UK, and serviced by a 165-strong network of independent pharmacies, now has the opportunity to be further implemented across PCS’s client base of 3,000 care homes in total.

Jonathan Papworth, co-founder of PCS, said: “I have been impressed with the proven capabilities built into Atlas, alongside the unique level of integration across GPs and pharmacies.

“Atlas is joining our family of social care products to provide best-in-class clinical software for our global customers, from digital care records to medication management and beyond.

“This will provide our joint customers with the opportunity to have full interoperability across our products, as well as the most comprehensive and capable integration with healthcare systems.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less